Thymulin

Thymulin (also known as Serum Thymic Factor or FTS - Facteur Thymique Sérique) is a 9-amino acid metallopeptide hormone produced exclusively by thymic epithelial cells. First characterized by Bach and colleagues in 1977, thymulin is unique in requiring zinc binding (1:1 equimolecular ratio) for biological activity. The zinc-thymulin complex adopts a specific three-dimensional conformation essential for its immunomodulatory functions, including T-cell differentiation, NK cell enhancement, and suppressor T-cell regulation. Beyond immune functions, thymulin demonstrates potent anti-inflammatory and analgesic properties through inhibition of NF-κB, p38 MAPK, and pro-inflammatory cytokines. Serum thymulin levels decline progressively with age (peaking in pre-adolescence), contributing to immunosenescence. Research shows promise in lung diseases, neuropathic pain, and age-related immune dysfunction, though human clinical trials remain limited.

• T-Cell Differentiation
• NK Cell Enhancement
• Cytokine Modulation

Immune modulation, T-cell differentiation, anti-inflammatory effects, potential analgesic properties

Zinc-dependent metallopeptide that binds to high-affinity T-cell receptors. Induces T-cell differentiation, enhances suppressor T-cell function, and modulates NK cell activity. Anti-inflammatory action via NF-κB inhibition, p38 MAPK suppression, and reduction of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6). May also act through α7-nicotinic acetylcholine receptor potentiation for analgesic effects.

Peak plasma concentration: 15 min. Elimination half-life: 10 min. Largely cleared by: ~51 min.

Research protocols from published literature — not dosing recommendations.

• Zinc Supplementation — Synergistic: Thymulin requires zinc for biological activity (1:1 equimolar binding). Zinc deficiency decreases thymulin activity; supplementation restores it. Co-administration essential for optimal effect.
• Thymosin Alpha-1 — Compatible: Both are thymic peptides but act through different mechanisms. Thymosin Alpha-1 works via TLR signaling while thymulin requires zinc binding. May be complementary for immune support.
• Thymosin Beta-4 — Compatible: Different functions -TB-4 focuses on tissue repair while thymulin modulates immune function. No known negative interactions.
• Epitalon — Compatible: Complementary anti-aging mechanisms. Epitalon targets telomerase/pineal function while thymulin addresses thymic/immune aging. Often used together in longevity protocols.
• Corticosteroids — Monitor Combination: Both have anti-inflammatory effects but different mechanisms. High-dose corticosteroids may suppress thymic function. Thymulin may offer steroid-sparing potential in lung diseases.
• NSAIDs — Compatible: PAT (thymulin analog) showed comparable efficacy to indomethacin in animal studies. Different mechanisms -may be additive for pain/inflammation.
• BPC-157 — Unknown: Both have anti-inflammatory properties through different pathways. No interaction studies available. Theoretically compatible.
• Humanin — Unknown: Both involved in aging-related pathways. Different mechanisms. No interaction data available.

Supplies:

• Thymulin lyophilized powder
• Bacteriostatic water or sterile water
• Zinc supplement (oral) for optimal activity
• Insulin syringes (29-31 gauge)
• Alcohol prep pads

1. 1Store lyophilized powder at -20°C until use
2. 2Allow vial to reach room temperature
3. 3Add sterile water slowly down vial side
4. 4Gently swirl until dissolved -do not shake
5. 5Solution should be clear; discard if cloudy
6. 6Use reconstituted solution within 7-10 days
7. 7Store reconstituted at 2-8°C
8. 8Ensure adequate zinc intake for biological activity

Day 1-3: No immediate effects expected given mechanism. Week 1-2: Potential immune parameter improvements (requires testing). For pain/inflammation: Effects may be noticeable within days in animal models. Immune reconstitution may require multiple cycles over months. Best results likely with adequate zinc status.

CRITICAL: Requires zinc for biological activity -supplement if needed. Very short serum half-life (~10 minutes). No toxicity observed even at high doses in preclinical studies. Did not affect normal physiological parameters in animal studies. No immunosuppressive effects unlike corticosteroids. Limited human safety data -preclinical research only. Circadian variation in natural thymulin -timing may matter. Not FDA approved for any indication.

CRITICAL: Requires zinc for biological activity -supplement if needed. Very short serum half-life (~10 minutes). No toxicity observed even at high doses in preclinical studies. Did not affect normal physiological parameters in animal studies. No immunosuppressive effects unlike corticosteroids. Limited human safety data -preclinical research only. Circadian variation in natural thymulin -timing may matter. Not FDA approved for any indication.

Thymulin should be stored at Lyophilized: -20°C. Reconstituted: 2-8°C, use within 7-10 days.